Who owns Definium Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DFTX from SEC Form 13F filings across 353 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 353 institutions disclosed 117.9M shares of Definium Therapeutics, Inc. worth $4.48B — about 86.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
353
13F holders
$4.48B
value, 2026 filers
86.7%
of shares outstanding (117.9M sh)
65
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DFTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.8M | $448.1M | 0.0% | 8.7% | +4.8% |
| 2 | FMR LLC | 9.1M | $345.7M | 0.0% | 6.7% | +91.1% |
| 3 | Capital World Investors | 8.3M | $314.2M | 0.0% | 6.1% | +53.8% |
| 4 | Janus Henderson Group Ltd.NEW | 7.2M | $273.9M | 0.1% | 5.3% | new |
| 5 | Avoro Capital Advisors LLC | 7.0M | $268.3M | 2.8% | 5.2% | -1.9% |
| 6 | Driehaus Capital Management LLC | 6.8M | $258.4M | 1.8% | 5% | -0.8% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.4M | $166.2M | 0.0% | 3.2% | -6.1% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 3.7M | $139.8M | 0.0% | 2.7% | +24.5% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 3.6M | $138.7M | 0.0% | 2.7% | 0.0% |
| 10 | STATE STREET CORP | 3.3M | $125.6M | 0.0% | 2.4% | +7.7% |
| 11 | Capital International Investors | 3.0M | $113.4M | 0.0% | 2.2% | +0.6% |
| 12 | Octagon Capital Advisors LP | 2.5M | $95.6M | 12.7% | 1.8% | -14.9% |
| 13 | ALLIANCEBERNSTEIN L.P. | 1.9M | $73.8M | 0.0% | 1.4% | +7.5% |
| 14 | GOLDMAN SACHS GROUP INC | 1.9M | $73.7M | 0.0% | 1.4% | +7.5% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | $63.0M | 0.0% | 1.2% | +0.4% |
| 16 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $61.6M | 0.0% | 1.2% | +8.9% |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.3M | $47.6M | 0.1% | 0.9% | +25.0% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $45.3M | 0.0% | 0.9% | +9.8% |
| 19 | NORTHERN TRUST CORP | 1.2M | $45.0M | 0.0% | 0.9% | +1.2% |
| 20 | AMERIPRISE FINANCIAL INC | 1.1M | $41.1M | 0.0% | 0.8% | -5.9% |
| 21 | Woodline Partners LP | 1.0M | $38.2M | 0.1% | 0.7% | 0.0% |
| 22 | Deep Track Capital, LP | 1.0M | $38.1M | 0.6% | 0.7% | -63.6% |
| 23 | LORD, ABBETT & CO. LLCNEW | 958,635 | $36.5M | 0.1% | 0.7% | new |
| 24 | UBS Group AG | 928,669 | $35.3M | 0.0% | 0.7% | +85.9% |
| 25 | Ensign Peak Advisors, Inc | 913,732 | $34.8M | 0.1% | 0.7% | +96.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.